Dysregulated cellular redox status during hyperammonemia causes mitochondrial dysfunction and senescence by inhibiting sirtuin‐mediated deacetylation
Saurabh Mishra,Nicole Welch,Manikandan Karthikeyan,Annette Bellar,Ryan Musich,Shashi Shekhar Singh,Dongmei Zhang,Jinendiran Sekar,Shuhui Wang Lorkowski,Ling Li,Belinda Willard,Jonathan D. Smith,Vidula Vachharajani,Avinash Kumar,Srinivasan Dasarathy,Amy H. Attaway,Aruna Chelluboyina,Sanjoy Roychowdhary,Charles L. Hoppel
DOI: https://doi.org/10.1111/acel.13852
IF: 11.005
2023-04-28
Aging Cell
Abstract:Ammonia is an endogenous cytotoxin that causes post‐mitotic senescence but the molecular mechanisms are poorly understood. Complementary multiomics, molecular, and metabolic analyses across a comprehensive array of preclinical models and human skeletal muscle show that mitochondrial oxidative dysfunction results in impaired oxidation of NADH with redox (NAD+/NADH ratio) imbalance. Consequent impairment in mitochondrial sirtuin 3, an NAD+ dependent deacetylase, results in hyperacetylation of cellular, primarily mitochondrial, proteins. Restoration of redox status, rather than targeting sirtuin 3 or providing NAD+ precursor, reversed cellular dysfunction and post‐mitotic senescence. Perturbed metabolism of ammonia, an endogenous cytotoxin, causes mitochondrial dysfunction, reduced NAD+/NADH (redox) ratio, and postmitotic senescence. Sirtuins are NAD+‐dependent deacetylases that delay senescence. In multiomics analyses, NAD metabolism and sirtuin pathways are enriched during hyperammonemia. Consistently, NAD+‐dependent Sirtuin3 (Sirt3) expression and deacetylase activity were decreased, and protein acetylation was increased in human and murine skeletal muscle/myotubes. Global acetylomics and subcellular fractions from myotubes showed hyperammonemia‐induced hyperacetylation of cellular signaling and mitochondrial proteins. We dissected the mechanisms and consequences of hyperammonemia‐induced NAD metabolism by complementary genetic and chemical approaches. Hyperammonemia inhibited electron transport chain components, specifically complex I that oxidizes NADH to NAD+, that resulted in lower redox ratio. Ammonia also caused mitochondrial oxidative dysfunction, lower mitochondrial NAD+‐sensor Sirt3, protein hyperacetylation, and postmitotic senescence. Mitochondrial‐targeted Lactobacillus brevis NADH oxidase (MitoLbNOX), but not NAD+ precursor nicotinamide riboside, reversed ammonia‐induced oxidative dysfunction, electron transport chain supercomplex disassembly, lower ATP and NAD+ content, protein hyperacetylation, Sirt3 dysfunction and postmitotic senescence in myotubes. Even though Sirt3 overexpression reversed ammonia‐induced hyperacetylation, lower redox status or mitochondrial oxidative dysfunction were not reversed. These data show that acetylation is a consequence of, but is not the mechanism of, lower redox status or oxidative dysfunction during hyperammonemia. Targeting NADH oxidation is a potential approach to reverse and potentially prevent ammonia‐induced postmitotic senescence in skeletal muscle. Since dysregulated ammonia metabolism occurs with aging, and NAD+ biosynthesis is reduced in sarcopenia, our studies provide a biochemical basis for cellular senescence and have relevance in multiple tissues.
cell biology,geriatrics & gerontology